Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.

Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.

To get the details: Click Here

[Close Window]
Medical Sales Jobs Websites - the best Medical Sales Jobs | Laboratory Sales Jobs | Medical Device Sales Jobs

Posts on ‘October 31st, 2008’

Pfizer’s TOVIAZ(TM) (fesoterodine fumarate) Receives FDA Approval for the Treatment of Overactive Bladder

New Once-Daily Treatment from Market Leader Shows Significant Efficacy over 24 Hours

Many People with Incontinence Conditions Suffer without Seeking Medical Help, Recent NIH Report Shows

NEW YORK–(HSMN NewsFeed)–Pfizer Inc said today that the U.S. …
Biopharmaceuticals, Urology, FDA
Pfizer, TOVIAZ, fesoterodine, overactive bladder

First Implant of DuraHeart(TM) Left Ventricular Assist System (LVAS) in Japanese Clinical Trial

ANN ARBOR, Mich., Oct. 31 (HSMN NewsFeed) — Terumo Heart Inc. announced that the first DuraHeart(TM) Left Ventricular Assist System (LVAS) was implanted in October at the University of Tokyo Hospital in Japan. Terumo Corporation will continue efforts to…
Devices, Cardiology
Terumo Heart, DuraHeart, Left Ventricular Assist System, Mag-Lev

Misonix Announces New Distribution Agreement for Greece

FARMINGDALE, N.Y.–(HSMN NewsFeed)–Misonix, Inc. (NASDAQ: MSON ), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of cancer and worldwide for other acute health conditions, has entered into …
Devices, Distribution
Misonix, ST-Medical, SonaStar, Ultrasonic Surgical Aspirator, BoneScalpel

Savient Submits Biologics License Application (BLA) for pegloticase

EAST BRUNSWICK, N.J., Oct. 31 (HSMN NewsFeed) — Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today announced the submission of its BLA to the U.S. Food and Drug Administration (FDA) seeking approval to market pegloticase in the United States along with…
Biopharmaceuticals
Savient Pharmaceuticals, pegloticase, gout

Alphatec Spine Expands European Presence; Names Peter Kohlbecher as Vice President, General Manager - Europe

Company Continues to Develop and Build Global Distribution Network

CARLSBAD, Calif., Oct. 31, 2008 — (HSMN NewsFeed) — Alphatec Holdings, Inc. (NasdaqGM:ATEC ), the parent company of Alphatec Spine, Inc., a medical device company that designs, develop…
Devices, Neurosurgery, Orthopaedic, Personnel
Alphatec Holdings, Alphatec Spine

Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS

Company Reaffirms Fiscal Year 2009 Revenue Guidance

HOUSTON, Oct. 31 (HSMN NewsFeed) — Cyberonics, Inc. (Nasdaq: CYBX ) today announced that the Centers for Medicare and Medicaid Services (CMS) has published the 2009 CMS Outpatient Prospective Paymen…
Devices, Neurology, Reimbursement
Cyberonics, VNS Therapy, Vagus Nerve Stimulation